概括
科学家们发现了一种DNA标记物,该标记物与囊性纤维化 (CF) 有遗传联系,这是一个常见的遗传性疾病. 这一发现缩小了对CF基因的搜索范围,为分子分析和了解疾病铺平了道路.
科学领域:
- 人类遗传学 人类遗传学
- 分子生物学分子生物学
- 疾病基因映射 疾病基因映射
背景情况:
- 囊性纤维化 (Cystic Fibrosis,CF) 是一种自体逆性疾病,影响大约2000名高加索儿童中的1名.
- 结核病的遗传基础需要精确的基因定位来进行分子分析和治疗开发.
研究的目的:
- 识别和映射与囊性纤维化基因遗传相关的DNA标记物.
- 为了缩小CF基因的染色体位置,以便进一步进行分子研究.
主要方法:
- 在39个人类家族的队列中进行了遗传链接分析.
- 一个多态DNA标记物 (D0CRI-917) 被测试了与CF位点和PON位点的联系.
主要成果:
- 在D0CRI-917DNA标记物和囊性纤维化基因之间建立了显著的遗传联系.
- 还发现DNA标记物D0CRI-917与PON位点有关,估计遗传距离为5厘米 (cM) 到PON和15厘米到CF.
- CF基因的位置被精确到人类基因组的约1%,大约3000万个基因对.
结论:
- 发现一种链接的DNA多态性代表了对囊性纤维化基因分子分析的关键第一步.
- 虽然目前的数据支持CF的单一位置,但遗传异质性的可能性需要进一步调查.
更多相关视频
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
相关概念视频
Pedigree Analysis
Overview
Mutations
Overview
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
